Navigation Links
Case Western Reserve University faculty named 2009 NorTech Innovation Award winner
Date:2/23/2009

NorTech, in partnership with Crain's Cleveland Business, today presented a 2009 NorTech Innovation Award to Eric J. Arts, Ph.D., for his development of a Biotech Platform to Detect, Monitor, and Treat Viral Diseases. Dr. Arts and his research team developed a set of diagnostic tests used by physicians and researchers to monitor the success of anti-HIV treatment by determining drug resistance and disease "strength" of the virus. The technology can also be used in academic research to better understand HIV/AIDS and to develop vaccines. Dr. Arts is an Associate Professor of Medicine in the Division of Infectious Diseases, Department of Medicine at Case Western Reserve University School of Medicine. He is also Director of the Uganda Laboratory Core for the Case Western Reserve University Center for Aids Research.

"It is an honor to receive the prestigious NorTech Innovation Award," said Dr. Arts. "My team and I appreciate this recognition of our decades of work and commitment to advancing the treatment and quality of life for patients with HIV/AIDS."

Dr. Arts is highly respected by his peers in the field of infectious disease. His research found that the heterogeneity of HIV type 1 has a significant impact on viral fitness, disease progression in the patient, emergence of drug resistance, and development of an effective vaccine. Although encompassing a broad range of topics, all of his research projects are related to HIV type 1 genetic diversity.

"Dr. Arts and his laboratory are a source of great pride for the School of Medicine. Their work is an excellent example of our institution's focus on translational research which ultimately results in improved care for patients," said Pamela B. Davis, M.D., Ph.D., Dean, School of Medicine, Case Western Reserve University. "We look forward to this technology's next generation of testing for conditions, such as hepatitis C, and the development of real-time influenza vaccines based on a season's dominant virus strains."

"Since 2000, NorTech has been recognizing technology leaders working at the forefront of research, development, and technology commercialization in Northeast Ohio," said Dorothy C. Baunach, President and CEO, of NorTech. "We believe the innovations being recognized today will lay the groundwork for building new technology industries for the future of our region."

Earlier this month, Case Western Reserve University and Diagnostic HYBRIDS Inc. signed an exclusive worldwide licensing agreement granting Diagnostic HYBRIDS rights to a novel yeast-based virus cloning technology invented by Dr. Arts. His technology is a step towards personalizing medicine based on the needs of each patient. In this case, physicians can use this assay to determine the effectiveness of a patient's anti-HIV medication. Compared with existing drug-resistance technology, Dr. Arts' technology is more sensitive, inexpensive, and provides better analysis of the body's response to medication.


'/>"/>

Contact: Jessica Studeny
jes91@case.edu
216-368-4692
Case Western Reserve University
Source:Eurekalert

Related medicine news :

1. Carestream Molecular Imaging Releases Western Blot Kits For Added Convenience, Better Performance
2. The Cooper Institute and UT Southwestern Announce Medical Research Collaboration
3. High-tech Texas hospitals see fewer complications, lower costs, UT Southwestern researcher finds
4. Womens Heart Health a Critical Focus at Northwestern Memorials Bluhm Cardiovascular Institute
5. UT Southwestern researchers identify protein that may explain healthy obesity
6. Case Western Reserve University School of Dental Medicine is Site for Ohio Dental Associations Give Kids a Smile State Kick-Off Program ... Legislators, Health Officials, Special Dignitaries to Attend Childrens Free Dental Care Program
7. UT Southwestern researchers discover brains memory buffer in single cells
8. UT Southwestern researchers find drug-coated stents less risky for heart bypass patients
9. Baxter and Northwestern University partner to target new life sciences projects
10. UT Southwestern University Hospitals transplant program recognized for increasing organ donor rates
11. Childhood anxiety disorders can and should be treated, according to UT Southwestern national expert
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... December 06, 2016 , ... ... the much-anticipated HydroFX for Water®. This first-of-its-kind water-soluble powder supplement has a ... world’s most powerful antioxidants, molecular hydrogen, HydroFX for Water transforms every day ...
(Date:12/6/2016)... ... December 06, 2016 , ... Keeping Gift Season Safe, In ... that are safe and age-appropriate for their recipients. This is the idea behind Safe ... the safety of items that would make good gifts for children. For companies that ...
(Date:12/6/2016)... ... December 06, 2016 , ... Specialty ... newly updated International Audit Protocol Consortium (IAPC) EHS audit protocol for Great ... understand the scope of their EHS regulatory obligations and rapidly collect, share, archive, ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... authorized OSHA Training Institute Education Center headquartered in Northern California, has announced the ... providing occupational safety and health training to public sector employees. , “The primary ...
(Date:12/6/2016)... , ... December 06, 2016 , ... ... to "Training" magazine’s 2017 Training Top 125 for their industry leading training methods ... annual award recognizes USA as among the global elite in employer-sponsored training and ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... United Kingdom , Dec. 5, 2016   ... leading global specialty pharmaceutical company, today announced that it ... 2017 Corporate Equality Index (CEI), a national benchmarking survey ... lesbian, gay, bisexual and transgender (LGBT) workplace equality, administered ... the ranks of 517 major U.S. businesses which also ...
(Date:12/5/2016)... , Dec. 5, 2016  Cornerstone Pharmaceuticals, Inc., ... presented data from two Phase I trials evaluating ... the 58th annual meeting of the American Society ... California . The two datasets show encouraging ... myeloid leukemia (AML) and T-cell non-Hodgkin,s lymphoma (T-cell ...
(Date:12/5/2016)... Colo. , Nov. 29, 2016 Several ... hosted by Accera, Inc. at 11 a.m. ... Annual International Conference on Clinical Trials for Alzheimer,s Disease ... of metabolism in Alzheimer,s disease and therapeutic targets that ... "Following the recent failure of another therapy ...
Breaking Medicine Technology: